Literature DB >> 20868701

Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient mice.

Hu Chen1, Hari Manev.   

Abstract

In wild-type (WT) mice, the antibiotic minocycline inhibits development of cocaine-induced locomotor sensitization. Some of the actions of minocycline may involve the 5-lipoxygenase (5-LOX) pathway. We used the model of 5-LOX-deficient mice to investigate whether 5-LOX participates in minocycline's influence on the effects of cocaine. Locomotor sensitization was induced by 4 daily cocaine injections and the phosphorylation status of GluR1 glutamate receptors was assayed in brain samples. Minocycline failed to affect cocaine sensitization in 5-LOX-deficient mice. In these mice, neither cocaine nor minocycline 4-day treatment altered GluR1 phosphorylation. In WT mice in which minocycline inhibited development of cocaine sensitization, a 4-day cocaine treatment increased GluR1 phosphorylation at both Ser831 and Ser845 sites in the frontal cortex but not the striatum; further, this effect was prevented by minocycline. Under basal conditions and in response to a single cocaine injection the levels of GluR1, GluR2, and GluR3 AMPA receptor subunits did not differ between WT and 5-LOX-deficient mice, but the response of GluR1 phosphorylation to a single cocaine injection was greater under the 5-LOX deficiency. Hence, in WT mice GluR1 phosphorylation increased only in the frontal cortex and only at the Ser831 site. In 5-LOX-deficient mice, acute cocaine injection increased both Ser831 and Ser845 phosphorylation both in the frontal cortex and in the striatum. We suggest that in studying minocycline's action on cocaine's effects and/or addiction in humans, it would be important to consider the characterization of the subjects' 5-LOX system. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868701      PMCID: PMC3019259          DOI: 10.1016/j.neuropharm.2010.09.006

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  38 in total

1.  Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Stephanie S O'Malley
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

2.  Region-specific alterations in glutamate receptor expression and subcellular distribution following extinction of cocaine self-administration.

Authors:  M Behnam Ghasemzadeh; Preethi Vasudevan; Christopher R Mueller; Chad Seubert; John R Mantsch
Journal:  Brain Res       Date:  2009-02-05       Impact factor: 3.252

3.  Locomotor sensitization to cocaine is associated with distinct pattern of glutamate receptor trafficking to the postsynaptic density in prefrontal cortex: early versus late withdrawal effects.

Authors:  M Behnam Ghasemzadeh; Preethi Vasudevan; Christopher Mueller
Journal:  Pharmacol Biochem Behav       Date:  2008-12-13       Impact factor: 3.533

4.  Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation.

Authors:  Michael C Oh; Victor A Derkach; Eric S Guire; Thomas R Soderling
Journal:  J Biol Chem       Date:  2005-11-04       Impact factor: 5.157

Review 5.  Genetics and pharmacogenetics of the leukotriene pathway.

Authors:  Kelan G Tantisira; Jeffrey M Drazen
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

6.  Acute and chronic cocaine differentially alter the subcellular distribution of AMPA GluR1 subunits in region-specific neurons within the mouse ventral tegmental area.

Authors:  D A Lane; A Jaferi; M J Kreek; V M Pickel
Journal:  Neuroscience       Date:  2010-05-27       Impact factor: 3.590

7.  Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors.

Authors:  Marta Imbesi; Tolga Uz; Radmila Manev; Rajiv P Sharma; Hari Manev
Journal:  Neurosci Lett       Date:  2008-10-07       Impact factor: 3.046

8.  Receptor binding activities of Chlorella on cysteinyl leukotriene CysLT, glutamate AMPA, ion channels, purinergic P 2Y, tachykinin NK2 receptors and adenosine transporter.

Authors:  Fong-Chi Cheng; Jin-Jye Feng; Kuo-Hsin Chen; Hideyo Imanishi; Masaki Fujishima; Hideo Takekoshi; Yo Naoki; Minoru Shimoda
Journal:  Phytother Res       Date:  2010-01       Impact factor: 5.878

9.  Central administration of minocycline and riluzole prevents morphine-induced tolerance in rats.

Authors:  Bohlool Habibi-Asl; Kambiz Hassanzadeh; Mohammad Charkhpour
Journal:  Anesth Analg       Date:  2009-09       Impact factor: 5.108

10.  Functional analysis of 5-lipoxygenase promoter repeat variants.

Authors:  Susanna Vikman; Romulo M Brena; Patrice Armstrong; Jaana Hartiala; Charles B Stephensen; Hooman Allayee
Journal:  Hum Mol Genet       Date:  2009-08-28       Impact factor: 6.150

View more
  6 in total

1.  Sleep Disturbance Alters Cocaine-Induced Locomotor Activity: Involvement of Striatal Neuroimmune and Dopamine Signaling.

Authors:  Soheil Kazemi Roodsari; Yan Cheng; Kirstin M Reed; Laurie L Wellman; Larry D Sanford; Woong-Ki Kim; Ming-Lei Guo
Journal:  Biomedicines       Date:  2022-05-18

2.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

Review 3.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

4.  Post-translational modification biology of glutamate receptors and drug addiction.

Authors:  Li-Min Mao; Ming-Lei Guo; Dao-Zhong Jin; Eugene E Fibuch; Eun Sang Choe; John Q Wang
Journal:  Front Neuroanat       Date:  2011-03-17       Impact factor: 3.856

5.  Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.

Authors:  P F Giannopoulos; J Chu; Y B Joshi; M Sperow; J-G Li; L G Kirby; D Praticò
Journal:  Mol Psychiatry       Date:  2013-03-12       Impact factor: 13.437

6.  An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome.

Authors:  Joseph C Grieco; Stephanie L Ciarlone; Maria Gieron-Korthals; Mike R Schoenberg; Amanda G Smith; Rex M Philpot; Helen S Heussler; Jessica L Banko; Edwin J Weeber
Journal:  BMC Neurol       Date:  2014-12-10       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.